Author: healthadmin

Men and women should probably avoid ultra-processed foods when trying to have children, according to a new study of 651 couples in Rotterdam, the Netherlands. The findings were published March 24 in the journal human reproductionfound that men with diets high in ultra-processed foods had lower fertility, while women with such diets had slower embryo growth during pregnancy and smaller yolk sacs to nourish the embryo during early development. The authors say their study is the first to assess how ultra-processed foods in both mothers’ and fathers’ diets affect early pregnancy and the couple’s ability to conceive. Ultra-processed foods, such…

Read More

Researchers at the Canadian Museum of Nature have identified a previously unknown extinct rhino species in the high Arctic. This amazingly well-preserved fossil skeleton was discovered in ancient lake sediments in Horton Crater on Devon Island, Nunavut. This discovery represents the northernmost species of rhinoceros ever recorded. Rhinos have a long evolutionary history spanning more than 40 million years and once lived on nearly every continent except South America and Antarctica. The newly identified “Arctic rhinoceros” lived during the early Miocene epoch, about 23 million years ago. It is most closely related to species that lived in Europe millions of…

Read More

An international consortium has made significant advances in the diagnosis of neurological diseases. A recent paper published in the journal Nature Medicine describes the discovery of a new quantitative biomarker in lumbar fluid (cerebrospinal fluid) that could help doctors more accurately diagnose Parkinson’s disease and Lewy body dementia. The consortium, led by Dr Katharina Bolsevich and Professor Charlotte Theunissen from the Amsterdam UMC Institute of Neurochemistry, with key contributions from Dr Sebastian Engelborgs, Professor at the Vrije Universiteit Bruxelles and Head of the Department of Neurology at the University of Brussels, focused on the protein DOPA decarboxylase. This protein plays…

Read More

Metabolic-associated fatty liver disease (MASLD) affects approximately 30% of people worldwide, but effective targeted therapies have long been lacking. Now, researchers have discovered an important genetic factor that worsens the condition. Even more surprising, the most effective way to target this factor may be vitamin B3, an already approved and widely available treatment. An international research team led by Professor Jang Hyun Choi of UNIST, in collaboration with Professor Hwayoung Yoon of Busan National University (PNU) and Professor Neunghwa Park of Ulsan University Hospital (UUH), identified microRNA-93 (miR-93) as a central regulator of MASLD. This is the first time this…

Read More

Playing a fast-paced action video game for an hour before bed can actually lower stress levels and improve certain memory skills the next day. A recent experiment found that these short gaming sessions had no negative effect on objective sleep quality in adults who don’t normally play video games. The research results were published in a magazine sleeping pills. The video game industry generates huge profits in the hundreds of billions of dollars worldwide each year. With the majority of young people and adults participating in digital play, questions regarding the physiological and psychological effects of gaming are of great…

Read More

Karyopharm’s Expovio has stalled in the clinic and market after gaining approval for the treatment of multiple myeloma and achieving sales of $120 million in its third year on the market. On Tuesday, the Massachusetts company provided results from a Phase 3 trial that it hopes will help its nuclear transportation modulator regain momentum. But investors didn’t share the company’s enthusiasm, and the stock price plummeted after the company’s initial public offering, which revealed other financial conditions for the company. By testing Expovio (selinexor) in combination with Incyte and Novartis’ blockbuster Jakafi (ruxolitinib) in patients with first-line myelofibrosis (MF), the…

Read More

Despite recent policy uncertainties, Wuxi Biologics’ focus on its US operations will continue to pay off in 2025, with the US accounting for the majority of the record number of projects the CRDMO secured last year. Throughout 2025, the China-based contractor won an impressive 209 new integrated projects, compared to 148 added in 2024, bringing the program total to 945, Wuxi Bio said in its full-year earnings report on Tuesday. About half of these new programs come from the US, which the company says reflects “strong momentum in the US biopharmaceutical sector.” The overall portion of the new project included…

Read More

Eli Lilly is scaling back the rollout of its traditional insulin in Europe, with plans to discontinue some products for “commercial reasons.” The company will remove several insulin products in some European countries, including rapid-acting, fast-acting, mixed-acting and long-acting repeat products of its products, including human insulin, insulin lispro and insulin glargine, the European Medicines Agency (EMA) announced on Monday. All of these retirements are expected to occur by the second quarter of 2027, although the specific products and retirement schedules will vary by European country. The exit includes versions of Humalog and Avasagra and comes as Lilly increasingly relies…

Read More

You’re reading the web version of DC Diagnosis, STAT’s twice-weekly newsletter about health and medical politics and policy. Sign up here to get it in your inbox on Tuesdays and Thursdays. Far-right influencer and conspiracy theorist Laura Loomer, who stalked Vinay Prasad before he first quit the FDA, is now directing her anger at a crying baby on a plane. News tips and pictures of crying babies (email protected) Or Signal’s John_Wilkerson.07. Who will be the next CDC candidate? The big news this week will likely be the announcement of the nominee for the next CDC director. STAT+ exclusive story…

Read More

UIC researchers have successfully repurposed the FDA-approved cancer drug doxorubicin to treat drug-resistant herpes. Their research is published in the journal Drug Resistance Updates. “This opens up an unexpected and potentially rapid path toward treating drug-resistant herpes infections,” said study leader Deepak Shukla, a virologist at the School of Medicine. “HSV-1 infection has serious and sometimes life-threatening consequences, and this drug has the potential to save lives.” Immune-compromised patients, including cancer patients, are particularly vulnerable to HSV-1 infection, which can lead to brain inflammation and organ failure if left untreated. Drug-resistant strains are especially difficult to eradicate. In 2024, Shukla’s…

Read More